Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Differential Antitumor Activity of 5-Aza-2'-deoxycytidine in Prostate Cancer DU145, 22RV1, and LNCaP Cells
Huiying Cheng, Sijie Tang, Xueqi Lian, et al.
Journal of Cancer (2021) Vol. 12, Iss. 18, pp. 5593-5604
Open Access | Times Cited: 10

Showing 10 citing articles:

Therapeutic targeting of DNA methylation alterations in cancer
Abigail V. Lee, Kevin Nestler, Katherine B. Chiappinelli
Pharmacology & Therapeutics (2024) Vol. 258, pp. 108640-108640
Closed Access | Times Cited: 19
Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges
Carlo Sorrentino, Emma Di Carlo
Cancers (2023) Vol. 15, Iss. 11, pp. 2885-2885
Open Access | Times Cited: 17
FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway
Shuai Ke, Zelin Liu, Qinghua Wang, et al.
Cancers (2022) Vol. 14, Iss. 16, pp. 3915-3915
Open Access | Times Cited: 15
From Therapy Resistance to Targeted Therapies in Prostate Cancer
Filipa Moreira‐Silva, Rui Henrique, Cármen Jerónimo
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Integrating the tumor-suppressive activity of Maspin with p53 in retuning the epithelial homeostasis: A working hypothesis and applicable prospects
Sijie Tang, Zhongli Ling, Jiajia Jiang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Mechanisms of action of Sappan lignum for prostate cancer treatment: network pharmacology, molecular docking and experimental validation
Wenna Li, Honglin Jiang, Weina Zhang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1
Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool
Vicente Herrero‐Aguayo, Prudencio Sáez-Martínez, Juan M. Jiménez-Vacas, et al.
Molecular Therapy — Nucleic Acids (2022) Vol. 27, pp. 1164-1178
Open Access | Times Cited: 7
The ethanol extract of Cyperus exaltatus var. iwasakii exhibits cell cycle dysregulation, ERK1/2/p38 MAPK/AKT phosphorylation, and reduced MMP-9-mediated metastatic capacity in prostate cancer models in vitro and in vivo
Hoon Kim, Byung‐Doo Hwang, Seongbin Cho, et al.
Phytomedicine (2023) Vol. 114, pp. 154794-154794
Closed Access | Times Cited: 3
ZFP36 Inhibits Tumor Progression of Human Prostate Cancer by Targeting CDK6 and Oxidative Stress
Dongbo Yuan, Yinyi Fang, Wei‐Ming Chen, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-24
Open Access | Times Cited: 5
Promoter Gene Methylation Regulates Clooxygenase-2 Expression in Androgen-Dependent and Independent Prostate Cancer Cells
Chung‐Yi Liu, Shih-Huan Su, Tzu-Hsuan Chang, et al.
World Journal of Oncology (2022) Vol. 13, Iss. 3, pp. 107-116
Open Access | Times Cited: 2
Page 1

Scroll to top